Nalitt Cancer Institute at Staten Island University Hospital is a clinical research site located in Staten Island, New York, United States 10305.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Nalitt Cancer Institute at Staten Island University Hospital has participated in 16 clinical trials.
Therapeutic areas: Breast Cancer, Stage IV Breast Cancer, Colorectal Cancer.
Sponsors: Eastern Cooperative Oncology Group, NSABP Foundation Inc, SWOG Cancer Research Network.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Staten Island
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nalitt Cancer Institute at Staten Island University Hospital has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nalitt Cancer Institute at Staten Island University Hospital has 16 clinical trials on record. Their work covers Breast Cancer, Stage IV Breast Cancer, Colorectal Cancer.
Nalitt Cancer Institute at Staten Island University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.